Current Enrolling Studies | UnityPoint Health - Peoria

Methodist Emergency Department

First Available Time :

Pekin Emergency Department

First Available Time :

Proctor Emergency Department

First Available Time :

Pekin Urgent Care

First Available Time :

Proctor First Care - East Peoria

2535 E. Washington St.
East Peoria, Illinois 61611

Closed Patients
Waiting Now

Proctor First Care - Peoria Heights

1120 E. War Memorial Drive
Peoria Heights, Illinois 61616

Closed Patients
Waiting Now

UnityPoint Clinic - Express (Morton)

1909 North Morton Avenue
Morton, Illinois 61550

Closed Patients
Waiting Now

UnityPoint Clinic - Express (Peoria)

8914 N. Knoxville Avenue
Peoria, Illinois 61604

Closed Patients
Waiting Now

UnityPoint Clinic - Express (Washington)

209 N. Cummings Lane
Washington, Illinois 61571

Closed Patients
Waiting Now
null

Currently Enrolling Clinical Studies

Adult Clinical Research Studies

Heart and Vascular Research

ANTHEM- Heart Failure

Autonomic Regulation Therapy To Enhance Myocardial Function and Reduce Progression of Heart Failure with Reduced Ejection Fraction

For more information please contact Amy at 309-672-3118. The Principal Investigator for this study is Dr. Alexander Adler.

BMAD - Heart Failure

Benefits of Microcor µCOR™ in Ambulatory Decompensated Heart Failure

For more information please contact Virginia at 309-672-3153. The Principal Investigator for this study is Dr. Alexander Adler.

COORDINATE - Diabetes (in Cardiovascular Patients)

COOrdinating CaRDIology CliNics RAndomized Trial of Interventions to Improve OutcomEs

For more information please contact Virginia at 309-672-3153. The Principal Investigators for this study are Dr. Alexander Adler and Dr. David Trachtenbarg.

DIAMOND - Heart Failure

A Multicenter, Double-blind, Placebo-controlled, Randomized Withdrawal, Parallel-Group Study of Patiromer for the Management of Hyperkalemia in Subject Receiving Renin-Angiotensin-Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure. 

For more information please contact Virginia at 309-672-3153. The Principal Investigator for this study is Dr. Alexander Adler.

LIFEVEST - Heart Failure

Heart Failure Optimization Study

For more information please contact Amy at 309-672-3118. The Principal Investigator for this study is Dr. Alexander Adler.

NODE - Paroxysmal Supraventricular Tachycardia

Multi-Centre, Multi-National, Open Label, Safety Study of Etripamil Nasal Spray for Patients with Paroxysmal Supraventricular Tachycardia

For more information please contact Deanna at 309-672-4808. The Principal Investigator for this study is Dr. Adel Mina.

PARAGLIDE - Heart Failure

A multicenter, randomized, double-blind, double-dummy, parallel group, active controlled 8-week study to evaluate the effect of sacubitril/valsartan (LCZ696) versus valsartan on changes in NT-proBNP and safety and tolerability of in hospital initiation of LCZ696 compared to valsartan in HFpEF patients with acute decompensated heart failure (ADHF) who have been stabilized during hospitalization.

For more information please contact Deanna at 309-672-4808. The Principal Investigator for this study is Dr. Alexander Adler.

SPIRRIT - Heart Failure

Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction

For more information please contact Virginia at 309-672-3153. The Principal Investigator for this study is Dr. Alexander Adler.

TRANSFORM - Heart Failure

ToRsemide compArisoN with furoSemide FOR Management of Heart Failure

For more information please contact Virginia at 309-672-3153. The Principal Investigator for this study is Dr. Alexander Adler.

Diabetes Research

ARISE - Diabetic Cardiomyopathy

A Multicenter, Randomized, Placebo-Controlled Study to Evaluate the Safety and Efficacy of AT-001 in Patients with Diabetic Cardiomyopathy / Stage B Heart Failure at High Risk of Progression to Overt Heart Failure (Stage C Heart Failure)

For more information please contact Deanna at 309-672-4808. The Principal Investigator for this study is Dr. David Trachtenbarg.

Gastrointestinal Research

RiCoDIFy - C-Difficile

Phase 3, randomized, double-blind, active controlled study to compare the efficacy and safety of ridinilazole (200 mg, bid) for 10 days with vancomycin (125 mg, qid) for 10 days in the treatment of Clostridium difficile infection (CDI).

For more information please contact Deanna at 309-672-4808. The Principal Investigator for this study is Dr. David Trachtenbarg.

Oncology Research

SEERPRO - Cancer

A Prospective Blood Sample Collection Study to Evaluate a Panel of Protein-based Biomarkers

For more information please contact Amy at 309-672-3118. The Principal Investigator for this study is Dr. Candace Correa.